Form 8-K - Current report:
SEC Accession No. 0001185185-24-000745
Filing Date
2024-08-01
Accepted
2024-08-01 10:09:05
Documents
14
Period of Report
2024-07-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K novaccess20240731_8k.htm   iXBRL 8-K 20457
  Complete submission text file 0001185185-24-000745.txt   151822

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA xsnx-20240726.xsd EX-101.SCH 3217
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xsnx-20240726_def.xml EX-101.DEF 10239
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE xsnx-20240726_lab.xml EX-101.LAB 19146
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xsnx-20240726_pre.xml EX-101.PRE 10572
16 EXTRACTED XBRL INSTANCE DOCUMENT novaccess20240731_8k_htm.xml XML 2649
Mailing Address 8584 E. WASHINGTON STREET, NO. 127 CHAGRIN FALLS OH 44023
Business Address 8584 E. WASHINGTON STREET, NO. 127 CHAGRIN FALLS OH 44023 (213) 642-9268
NovAccess Global Inc. (Filer) CIK: 0001039466 (see all company filings)

EIN.: 841384159 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-29621 | Film No.: 241164847
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)